You are here

Coronary Intervention & Surgery

 

More than 11 percent of patients who developed perioperative MI after vascular surgery and underwent MI died within 30 days of the noncardiac procedure, according to an observational study.

 

 

Recent Headlines

Surgeon specialization may predict 30-day operative mortality following cardiac procedures

A surgeon’s degree of specialization helped predict 30-day operative mortality in some common cardiology procedures, according to a retrospective analysis of Medicare data.

Systematic review finds evidence is lacking for percutaneous LAA exclusion as an alternative to oral anticoagulation

A systematic review of the published literature found that there was no evidence to recommend percutaneous left atrial appendage (LAA) exclusion in patients with atrial fibrillation who are ineligible for anticoagulation.

Mortality rate remains high in patients undergoing PCI for an MI following noncardiac surgery

More than 11 percent of patients who developed perioperative MI after vascular surgery and underwent MI died within 30 days of the noncardiac procedure, according to an observational study.

Mitral valve repair device 100 percent successful in first human clinical study

Researchers at the University of Maryland School of Medicine have developed a device that has a 100 percent success rate in repairing the mitral heart valve in its first human clinical study, with results published in the journal Circulation.

Scoring system may help predict 30-day and one-year mortality following TAVR

Researchers identified predictors of 30-day and one-year mortality in patients who have undergone transcatheter aortic valve replacement (TAVR) and developed a scoring system that may help forecast mortality following TAVR.

Trial examines the Tryton stent for use in patients with large side branches

A prospective study found that the use of the Tryton side branch stent in patients undergoing PCI was effective in treating coronary artery bifurcations involving large side branches.

CMS grants IDE to MedStar for trial examining TAVR devices

The Centers for Medicare & Medicaid Services (CMS) granted the Medstar Research Institute an investigational device exemption to conduct a prospective transcatheter aortic valve replacement (TAVR) trial.

FDA approves Medtronic’s drug-coated balloon in a longer length

The FDA approved new versions of Medtronic’s IN.PACT Admiral drug-coated balloon on July 13 to treat patients with peripheral artery disease.

BayCare Health first to implant world’s smallest pacemaker

BayCare Health System, a nonprofit healthcare provider in Clearwater, Fla., became the first to implant the world’s smallest pacemaker in June.

Arizona marathon runner receives first dissolvable heart stent

A dissolvable heart stent, just recently approved by the FDA, was implanted into a patient for the first time this week, a significant advancement in cardiovascular care.

Pages